Essex Bio-Technology Limited, an investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally. It opera...
Essex Bio-Tech files HKEX next-day return disclosing share repurchase at HKD 2.28-2.25
Essex Bio-Tech files HKEX next-day return disclosing share buyback at HKD 2.3
Essex Bio-Tech files HKEX next-day return on share buyback at HKD 2.3
Grand Pharma's FDA Nod and Sihuan's Aesthetics Pivot Highlight HK Market Shifts
Essex Bio-Tech files HKEX next-day return disclosing share repurchase at HKD 2.37
Essex Bio-Technology Reports Profit Decline but Strong Balance Sheet in First-Half 2026